Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for Non-small Cell Lung Cancer (NSCLC)
12 locations incl. Los Angeles
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT07154706·Phase 3·Recruiting